
---
title: '江苏吴中：两药品通过仿制药一致性评价'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=7510'
author: 证券时报网
comments: false
date: Tue, 16 Nov 2021 16:50:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=7510'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS600200" style="color: #2f67d1;text-decoration: none;" code="600200" target="_blank">江苏吴中</a>(600200)11月16日晚间公告，美索巴莫注射液首家通过仿制药一致性评价，注射用兰索拉唑通过仿制药一致性评价。</p>

                  
</div>
            